Equity Capital Markets

Klaviyo Inc.

05/25
|
$372.9 Million
klaviyo
Piper Sandler served as bookrunner for Klaviyo Inc. on its follow-on offering
Sub-Type
Follow-On Offering
Sector
Technology
Sub-Sector
Software

Related Transactions

All Transactions
$75.0 Million
w
Protara Therapeutics
Confidentially Marketed Follow-On Offering
Active Bookrunner
$172.5 Million
e
Capricor Therapeutics
Confidentially Marketed Follow-On Offering
Left Bookrunner
$158.7 Million
s
Kestra Medical Technologies
Follow-On Offering
Active Bookrunner
$300.0 Million
s
Compeer Financial
Perpetual Preferred Stock
Sole Initial Purchaser
4
American Integrity Insurance Group
Follow-On Offering
Active Bookrunner
$373.0 Million
z
Central Bancompany
Initial Public Offering
Joint Bookrunner
$40.2 Million
s
Fennec Pharmaceuticals
Confidentially Marketed Follow-On Offering
Lead Bookrunner
$172.5 Million
p
Inventiva Pharma
Confidentially Marketed Follow-On Offering
Active Bookrunner
g
MultiPlan, Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$110.0 Million
3
Nektar Therapeutics
ATM Program Common Stock
Lead Sales Agent
$28.8 Million
e
Inovio Pharmaceuticals
Confidentially Marketed Follow-On Offering
Sole Manager
$314.0 Million
f
BillionToOne
Initial Public Offering
Active Bookrunner
$40.0 Million
r
Colony Bank
ATM Program Common Stock
Sole Sales Agent
$130.0 Million
h
Savara
Confidentially Marketed Follow-On Offering
Active Bookrunner
u
Tamboran Resources
Confidentially Marketed Follow-On Offering
Co-Manager
$603.8 Million
r
Praxis Precision Medicines
Confidentially Marketed Follow-On Offering
Active Bookrunner

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.